| [1] |
Maniotis AJ, Folberg R, Hess A, et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry[J]. Am J Pathol,1999, 155(3):739-52.
|
| [2] |
Folberg R, Maniotis AJ. Vasculogenic mimicry[J]. APMIS,2004,1 12 (7-8):508-25.
|
| [3] |
Baeten CI, Hillen F, Pauwels P, et al. Prognostic role of vasculogenic mimicry in colorectal cancer[J]. Dis Colon Rectum, 20 09, 52(12):2028-35.
|
| [4] |
Mihic-Probst D, Ikenberg K, Tinguely M, et al. Tumor cell plasticity and angiogenesis in human melanomas[J]. PLoS One, 20 12, 7(3):e33571.
|
| [5] |
Borthwick LA, Parker SM, Brougham KA, et al. Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation[J]. Thorax, 2009, 64(9):770-7.
|
| [6] |
Sun T, Zhao N, Zhao XL, et al. Expression and functional significance of Twist1 in hepatocellular carcinoma: its role in vasculogenic mimicry[J].Hepatology,2010, 51(2):545-56.
|
| [7] |
Comito G, Calvani M, Giannoni E, et al. HIF-1α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells[J]. Free Radic Biol Med, 20 11, 51(4):893-904.
|
| [8] |
Che N, Zhao XL, Sun T, et al. The role of Twist1 in hepatocellular carcinoma angiogenesis: a clinical study[J]. Hum Pathol, 2011, 42 (6):840-7.
|
| [9] |
Sun T, Sun BC, Zhao XL, et al. Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: a study of hepatocellular carcinoma[J]. Hepatology, 2011, 54(5):1690-706.
|
| [10] |
Liu Z, sun B, Qi L, et al. Zinc finger E-box binding homeobox 1 promotes vasculogenic mimicry in colorectal cancer through induction of epithelial-to-mesenchymal transition[J]. Cancer Sci,2012,103(4):813-20.
|
| [11] |
Yu Z, Pestell TG, Lisanti MP, et al. Cancer stem cells[J]. Int J Biochem Cell Biol, 2012, 44(12):2144-51.
|
| [12] |
Lirdprapamongkol K, Chiablaem K, Sila-Asna M, et al. Exploring stemness gene expression and vasculogenic mimicry capacity in well- and poorly-differentiated hepatocellular carcinoma cell lines[J]. Biochem Biophys Res Commun,2012, 422(3):429-35.
|
| [13] |
Chiao MT, Yang YC, Cheng WY, et al. CD133+ glioblastoma stem-like cells induce vascular mimicry in vivo[J].Curr Neurovasc Res, 2011,8(3):210-9.
|
| [14] |
Valyi-Nagy K, Kormos B, Ali M,et al. Stem cell marker CD271 is expressed by vasculogenic mimicry-forming uveal melanoma cells in three-dimensional cultures[J]. Mol Vis, 2012,18:588-92.
|
| [15] |
Yao XH, Ping YF, Bian XW. Contribution of cancer stem cells to tumor vasculogenic mimicry[J]. Protein Cell, 2011, 2(4):266-72.
|
| [16] |
Liu TJ, Sun BC, Zhao XL, et al. CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triplenegative breast cancer[J]. Oncogene,2013, 32(5):544-53.
|
| [17] |
Yang MH,Hsu DS,Wang HW,et al. Bmi1 is essential in Twist1- induced epithelial-mesenchymal transition[J]. Nat Cell Biol, 2010, 12 (10):982-92.
|
| [18] |
Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells[J]. Cell, 20 08, 133(4):704-15.
|
| [19] |
Bao B, Ali S, Ahmad A, et al. Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment[J]. PLoS One, 2012, 7(12):e50165.
|
| [20] |
Vartanian A, Stepanova E, Grigorieva I, et al. VEGFR1 and PKCα signaling control melanoma vasculogenic mimicry in a VEGFR2 kinase-independent manner[J]. Melanoma Res, 2011, 21(2):91-8.
|
| [21] |
Frank NY, Schatton T, Kim S, et al. VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth[J]. Cancer Res, 2011, 71(4):1474-85.
|
| [22] |
Karroum A,Mirshahi P,Faussat AM,et al. Tubular network formation by adriamycin-resistant MCF-7 breast cancer cells is closely linked to MMP-9 and VEGFR-2/VEGFR-3 overexpressions[ J] Eur J Pharmacol,2012,685(1-3):1-7.
|
| [23] |
Yang J, Li TZ, Xu GH, et al. Low-concentration capsaicin promotes colorectal cancer metastasis by triggering ROS production and modulating Akt/mTOR and STAT-3 pathways[J]. Neoplasma, 20 13, 60(4):364-72.
|
| [24] |
Sood AK, Seftor EA, Fletcher MS, et al. Molecular determinants of ovarian cancer plasticity[J]. Am J Pathol, 2001, 158(4):1279-88.
|
| [25] |
Hess AR, Seftor EA, Seftor RE, et al. Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry[J]. Cancer Res, 2003, 63(16):4757-62.
|
| [26] |
Chen LX, He YJ, Zhao SZ, et al. Inhibition of tumor growth and vasculogenic mimicry by curcumin through down-regulation of the EphA2/PI3K/MMP pathway in a murine choroidal melanoma model[J]. Cancer Biol Ther, 2011, 11(2):229-35.
|
| [27] |
Cong R, Sun Q, Yang L, et al. Effect of Genistein on vasculogenic mimicry formation by human uveal melanoma cells[J]. J Exp Clin Cancer Res, 2009, 28:124.
|
| [28] |
van der Schaft DW, Seftor RE, Seftor EA, et al. Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells[J]. J Natl Cancer Inst, 2004, 96 (19):1473-7.
|
| [29] |
Conley SJ, Gheordunescu E, Kakarala P, et al. Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia[J]. Proc Natl Acad Sci U S A, 2012, 109(8):2784-9.
|
| [30] |
Xu Y, Li Q, Li XY, et al. Short-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasis[J]. J Exp Clin Cancer Res, 2012, 31 :16.
|
| [31] |
Li JL, Sainson RC, Oon CE, et al. DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo[J]. Cancer Res, 20 11, 71(18):6073-83.
|
| [32] |
Wang R, Chadalavada K, Wilshire J, et al. Glioblastoma stemlike cells give rise to tumour endothelium[J]. Nature, 2010, 46 8(7325):829-33.
|
| [33] |
Chen LX, He YJ, Zhao SZ, et al. Inhibition of tumor growth and vasculogenic mimicry by curcumin through down-regulation of the EphA2/PI3K/MMP pathway in a murine choroidal melanoma model[J]. Cancer Biol Ther, 2011, 11(2):229-35.
|
| [34] |
Zhang S, Li M, Gu Y, et al. Thalidomide infl uences growth and vasculogenic mimicry channel formation in melanoma[J]. J Exp Clin Cancer Res, 2008, 27:60.
|
| [35] |
Su M, Feng YJ, Yao LQ, et al. Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo[J]. Int J Gynecol Cancer, 2008, 18(3):476-86.
|
| [36] |
Soda Y,Marumoto T,Friedmann-Morvinski D,et al. Transdifferentiation of glioblastoma cells into vascular endothelial cells[J]. Proc Natl Acad Sci U S A, 2011, 108(11):4274-80.
|
| [37] |
Xing Y, Zhang X, Zhao K, et al. Beneficial effects of sulindac in focal cerebral ischemia: a positive role in Wnt/beta-catenin pathway[J]. Brain Res, 2012, 1482:71-80.
|
| [38] |
Krop I, Demuth T, Guthrie T, et al. Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors[J]. J Clin Oncol, 2012, 30(19):2307-13.
|
| [39] |
Cheng XS, Yang ZB, Yin ZF. Matrix metalloproteinases and epithelial-mesenchymal transition in tumor: an advance[J]. Zhongguo Zhong Liu Sheng Wu Zhi Liao Za Zhi, 2011,18(4):437-40. [程先硕,杨之斌,殷正丰. 基质金属蛋白酶与肿瘤上皮间质转化 的研究进展[J].中国肿瘤生物治疗杂志, 2011,18(4):437-40.]
|
下载:
